Non-Small Cell Lung Carcinoma | Non-Small Cell Lung Carcinoma Subtype Any | Non-Small Cell Lung Carcinoma Intraoperative
Item
histologically or cytologically confirmed diagnosis of nsclc (any subtype). for patients entering arm b is also allowed to confirm histopathological diagnosis of nsclc intraoperatively during this trial.
boolean
C0007131 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C0449560 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
C0007131 (UMLS CUI [3,1])
C0456904 (UMLS CUI [3,2])
TNM clinical staging
Item
node positive (clinically or pathologically) stage ii disease or stage iiia: t1n1 or t2n1 or t1n2 or t2n2 or t3n1 or t3 n2, according to the revision by mountain cf of american joint committee on cancer (mountain cf 1997, fleming id et al. 1997). for patient entering arm b (with n0 stage) confirmation of n1-n2 stage must be obtained from intraoperative or post-surgery pathology report.
boolean
C3258246 (UMLS CUI [1])
Malignant Neoplasm Amenable Excision Curative
Item
tumor amenable to curative surgical resection.
boolean
C0006826 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0728940 (UMLS CUI [1,3])
C1276305 (UMLS CUI [1,4])
Measurable Disease
Item
patients with clinically measurable lesions will be enrolled in this study. measurability is determined according to recist criteria.
boolean
C1513041 (UMLS CUI [1])
Evaluation Pathological Post Mediastinoscopy | Evaluation Pathological Post Operative Surgical Procedures
Item
• pathological evaluation is performed after mediastinoscopy or after surgery
boolean
C1261322 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
C0025065 (UMLS CUI [1,4])
C1261322 (UMLS CUI [2,1])
C1521733 (UMLS CUI [2,2])
C0687676 (UMLS CUI [2,3])
C0543467 (UMLS CUI [2,4])
cancer treatment | Operative Surgical Procedures | Therapeutic radiology procedure | Chemotherapy | Immunotherapy | Molecular Targeted Therapy
Item
no prior tumor therapy (surgery, radiotherapy, chemotherapy, immunotherapy, molecular targeted therapy, or any other type of tumor therapy).
boolean
C0920425 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C0021083 (UMLS CUI [5])
C2699893 (UMLS CUI [6])
Investigational New Drugs
Item
treatment within the last 30 days with any investigational drug.
boolean
C0013230 (UMLS CUI [1])
cancer treatment | Therapeutic radiology procedure | Cytotoxic Chemotherapy | Immunotherapy | Molecular Targeted Therapy
Item
concurrent administration of any other tumor therapy, including radiotherapy, cytotoxic chemotherapy, immunotherapy, molecular target therapy.
boolean
C0920425 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0677881 (UMLS CUI [3])
C0021083 (UMLS CUI [4])
C2699893 (UMLS CUI [5])
Comorbidity Serious | Heart failure | poorly controlled diabetes mellitus
Item
serious concomitant disorders (for example, heart failure, poorly controlled diabetes) at the investigator’s discretion.
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0018801 (UMLS CUI [2])
C0554876 (UMLS CUI [3])
Communicable Disease Uncontrolled Requirement Therapeutic procedure
Item
presence of an uncontrolled, active infection requiring therapy (at the discretion of investigator.).
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
TNM clinical staging
Item
stage iiib or iv.
boolean
C3258246 (UMLS CUI [1])